Fig. 4From: The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinomaDisease-Specific Survival (DSS) according to the presence of TP53 mutation. The 3-year DSS rate of patients with wild-type TP53 was significantly longer than that of patients with TP53 mutations (94% vs 55%, P = 0.01)Back to article page